Ramin Farhood
À propos de l'auteur
Dr. RAMIN FARHOOD, senior VP at SSI Strategy, has over twenty-five years in patient-centric medical strategy. Previously at Novartis, he launched the world’s first gene therapy for spinal muscular atrophy. Farhood cofounded the Medical Affairs Professional Society (MAPS) and the Immunoglobulin National Society (IgNS) and cohosts The Emerging Biotech Leader podcast.
Voices of Oncology
Fostering a Collaborative Community of Experts to Accelerate Cancer Cures
Kirk V. Shepard, Ramin Farhood